Home Federal Bank Of Tennessee Eli Lilly & CO Transaction History

Home Federal Bank Of Tennessee

  • $334 Million
  • Q1 2025

A detailed history of Home Federal Bank Of Tennessee transactions in Eli Lilly & CO stock. As of the latest transaction made, Home Federal Bank Of Tennessee holds 11,776 shares of LLY stock, worth $9.13 Million. This represents 2.91% of its overall portfolio holdings.

Number of Shares
11,776
Previous 11,876 0.84%
Holding current value
$9.13 Million
Previous $9.17 Million 6.08%
% of portfolio
2.91%
Previous 2.73%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 15, 2025
SELL
$725.72 - $929.72 $72,572 - $92,972
-100 Reduced 0.84%
11,776 $9.73 Million
Q4 2024

Jan 24, 2025
SELL
$727.2 - $932.06 $829,735 - $1.06 Million
-1,141 Reduced 8.77%
11,876 $9.17 Million
Q3 2024

Oct 21, 2024
SELL
$772.14 - $960.02 $202,300 - $251,525
-262 Reduced 1.97%
13,017 $11.5 Million
Q2 2024

Jul 17, 2024
SELL
$724.87 - $909.04 $9,423 - $11,817
-13 Reduced 0.1%
13,279 $12 Million
Q1 2024

Apr 17, 2024
SELL
$592.2 - $792.28 $103,042 - $137,856
-174 Reduced 1.29%
13,292 $10.3 Million
Q4 2023

Jan 18, 2024
SELL
$525.19 - $619.13 $338,747 - $399,338
-645 Reduced 4.57%
13,466 $7.85 Million
Q3 2023

Oct 23, 2023
SELL
$434.7 - $599.3 $562,067 - $774,894
-1,293 Reduced 8.39%
14,111 $7.58 Million
Q2 2023

Jul 18, 2023
SELL
$350.74 - $468.98 $3,507 - $4,689
-10 Reduced 0.06%
15,404 $7.22 Million
Q1 2023

Apr 14, 2023
SELL
$310.63 - $364.82 $40,381 - $47,426
-130 Reduced 0.84%
15,414 $5.29 Million
Q4 2022

Jan 19, 2023
SELL
$321.55 - $374.67 $375,248 - $437,239
-1,167 Reduced 6.98%
15,544 $0
Q3 2022

Oct 18, 2022
SELL
$296.48 - $337.87 $66,708 - $76,020
-225 Reduced 1.33%
16,711 $5.4 Million
Q2 2022

Jul 15, 2022
SELL
$278.73 - $327.27 $62,714 - $73,635
-225 Reduced 1.31%
16,936 $5.49 Million
Q1 2022

Apr 12, 2022
SELL
$234.69 - $291.66 $386,065 - $479,780
-1,645 Reduced 8.75%
17,161 $4.91 Million
Q4 2021

Jan 12, 2022
SELL
$224.85 - $279.04 $253,181 - $314,199
-1,126 Reduced 5.65%
18,806 $5.2 Million
Q3 2021

Oct 13, 2021
SELL
$221.6 - $272.71 $29,916 - $36,815
-135 Reduced 0.67%
19,932 $4.61 Million
Q2 2021

Jul 13, 2021
SELL
$180.55 - $233.54 $148,953 - $192,670
-825 Reduced 3.95%
20,067 $4.61 Million
Q1 2021

Apr 09, 2021
SELL
$164.32 - $212.72 $9,859 - $12,763
-60 Reduced 0.29%
20,892 $3.9 Million
Q4 2020

Jan 11, 2021
SELL
$130.46 - $172.63 $46,313 - $61,283
-355 Reduced 1.67%
20,952 $3.54 Million
Q3 2020

Oct 09, 2020
SELL
$146.22 - $169.13 $5,848 - $6,765
-40 Reduced 0.19%
21,307 $3.15 Million
Q2 2020

Jul 08, 2020
SELL
$136.42 - $164.18 $4,092 - $4,925
-30 Reduced 0.14%
21,347 $3.51 Million
Q1 2020

Apr 10, 2020
SELL
$119.05 - $147.35 $2,976 - $3,683
-25 Reduced 0.12%
21,377 $2.97 Million
Q3 2019

Oct 10, 2019
SELL
$106.79 - $116.16 $32,037 - $34,848
-300 Reduced 1.38%
21,402 $2.39 Million
Q2 2019

Jul 11, 2019
BUY
$110.79 - $129.32 $3,988 - $4,655
36 Added 0.17%
21,702 $2.41 Million
Q1 2019

Apr 16, 2019
SELL
$111.31 - $131.02 $15,026 - $17,687
-135 Reduced 0.62%
21,666 $2.81 Million
Q4 2018

Jan 14, 2019
SELL
$105.9 - $118.64 $22,662 - $25,388
-214 Reduced 0.97%
21,801 $2.52 Million
Q3 2018

Oct 11, 2018
SELL
$85.86 - $107.31 $21,465 - $26,827
-250 Reduced 1.12%
22,015 $2.36 Million
Q2 2018

Jul 17, 2018
SELL
$75.7 - $86.88 $17,032 - $19,548
-225 Reduced 1.0%
22,265 $1.9 Million
Q1 2018

Apr 09, 2018
SELL
$74.21 - $87.6 $1,187 - $1,401
-16 Reduced 0.07%
22,490 $1.74 Million
Q3 2017

Nov 02, 2017
BUY
$77.07 - $85.54 $1.73 Million - $1.93 Million
22,506
22,506 $1.93 Million

Others Institutions Holding LLY

# of Institutions
4,395
Shares Held
821M
Call Options Held
10M
Put Options Held
10.8M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $737B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Home Federal Bank Of Tennessee Portfolio

Follow Home Federal Bank Of Tennessee and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Home Federal Bank Of Tennessee, based on Form 13F filings with the SEC.

News

Stay updated on Home Federal Bank Of Tennessee with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email